Aberrant CST1 expression has been reported to be associated with the occurrence, proliferation, invasion, and recurrence of several malignancies, including breast, pancrea, lung, hepatocellular carcinomas and gastric cancer [4–10]. Here, CST1 is linked to gastric cancer.